Patient Capital Management’s Western Alliance Bancorporation WAL Stock Holding History

Patient Capital Management’s Portfolio WAL Stock Details WAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-28,282	Closed	-$2.36M	–	45
2024 Q4	$2.36M	Sell	28,282 -207,210	-88%	-$18.2M	0.11%	37
2024 Q3	$20.4M	Sell	235,492 -149,255	-39%	-$11.5M	1%	32
2024 Q2	$24.2M	Sell	384,747 -66,144	-15%	-$4M	1.28%	31
2024 Q1	$28.9M	Sell	450,891 -5,992	-1%	-$368K	1.41%	31
2023 Q4	$30.1M	Sell	456,883 -1,472	-0.3%	-$74.3K	1.59%	31
2023 Q3	$21.1M	Buy	458,355 +16,948	+4%	+$800K	1.24%	32
2023 Q2	$16.1M	Buy	+441,407	New	+$15.3M	0.9%	32

Other funds holding WAL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DAM

Davis Asset Management Sausalito, California $3.95B AUM 11.79% 1-Year Est. Return

Patient Capital Management's WAL Position: Q1 2025 in Review

Patient Capital Management sold out of Western Alliance Bancorporation (WAL) in Q1 2025, closing a stake of 28,282 shares — an estimated $2.36M sold.

Patient Capital Management first reported a position in WAL in Q2 2023 and held it in 7 quarters. The position peaked at $30.1M in Q4 2023. 414 funds tracked by Wall St. Rank hold WAL as of Q1 2025.

Patient Capital Management reported no remaining Western Alliance Bancorporation position as of Q1 2025 after selling out during the quarter.
Patient Capital Management sold 28,282 Western Alliance Bancorporation shares in Q1 2025, an estimated $2.36M.
Patient Capital Management first reported a position in Western Alliance Bancorporation in Q2 2023 and held it in 7 quarters.
Patient Capital Management's Western Alliance Bancorporation position peaked at $30.1M in Q4 2023.
414 funds tracked by Wall St. Rank held Western Alliance Bancorporation as of Q1 2025.

Based on Patient Capital Management's 13F filing for Q1 2025, filed 14 May 2025.